Last updated on 17 Aug 2023
Owner Info
Empress Therapeutics, Inc.
55 Cambridge Parkway, Suite 800E
Cambridge MA 02142, UNITED STATES OF AMERICA
Serial Number
2361191 filed on 1 Mar 2023
Correspondent
Christina M. Licursi Wolf, Greenfield & Sacks, P.C.
600 Atlantic Avenue,
Boston MA 02210,
UNITED STATES OF AMERICA
2361191
1 Mar 2023
1 Mar 2033
WORD
2 Sept 2022
US
Status Date | Action Taken |
---|---|
17th Aug 2023 | International Registration in Australia Protected correspondence sent |
16th Aug 2023 | IP Right Registration Published |
16th Aug 2023 | Status change to Registered/Protected |
10th Jun 2023 | Application Accepted correspondence sent |
9th Jun 2023 | IP Right has been Examined |
9th Jun 2023 | IP Right Acceptance Published |
9th Jun 2023 | Status change to Accepted |
8th Jun 2023 | Awaiting examination |
8th Jun 2023 | Examination expedited |
1st Jun 2023 | IP Right Filed Published |